Prognostic model using (18)F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma

Investigating prognostic factors in patients with relapsed or primary refractory classical Hodgkin lymphoma (R/R cHL) is essential to optimize risk-adapted treatment strategies. We built a prognostic model using baseline quantitative (18)F-fluorodeoxyglucose positron emission tomography (PET) radiom...

Descripción completa

Detalles Bibliográficos
Autores principales: Driessen, Julia, Zwezerijnen, Gerben J. C., Schöder, Heiko, Kersten, Marie José, Moskowitz, Alison J., Moskowitz, Craig H., Eertink, Jakoba J., Heymans, Martijn W., Boellaard, Ronald, Zijlstra, Josée M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651466/
https://www.ncbi.nlm.nih.gov/pubmed/37722357
http://dx.doi.org/10.1182/bloodadvances.2023010404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651466/
https://www.ncbi.nlm.nih.gov/pubmed/37722357
http://dx.doi.org/10.1182/bloodadvances.2023010404

Ejemplares similares